These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 1301342
1. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation]. Wang SH. Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342 [Abstract] [Full Text] [Related]
2. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. Soloway MS, Jordan AM, Murphy WM. Prog Clin Biol Res; 1989 Jul; 310():215-36. PubMed ID: 2505268 [Abstract] [Full Text] [Related]
3. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence]. Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF. Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813 [Abstract] [Full Text] [Related]
4. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J. Croat Med J; 2003 Apr 15; 44(2):187-92. PubMed ID: 12698510 [Abstract] [Full Text] [Related]
5. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P. Prog Clin Biol Res; 1989 Apr 15; 310():237-52. PubMed ID: 2505269 [Abstract] [Full Text] [Related]
6. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M, McGarry R, Kupelnick B. Anticancer Res; 2001 Apr 15; 21(1B):765-9. PubMed ID: 11299841 [Abstract] [Full Text] [Related]
7. [Prevention of postoperative recurrence of human bladder carcinoma by intravesical instillation of immunotoxin, a clinical study]. Tong M, Yu LZ, Ding Y, Liu LB, Pan BN, Na YQ. Zhonghua Yi Xue Za Zhi; 2003 Feb 10; 83(3):201-3. PubMed ID: 12812661 [Abstract] [Full Text] [Related]
8. [Intravesical instillation in the treatment of superficial tumors of the bladder]. Chopin DK. Prog Urol; 1998 Apr 10; 8(2):268-73. PubMed ID: 9615941 [Abstract] [Full Text] [Related]
10. [Superficial bladder cancer: prophylaxis of recurrence and progression]. Miyanaga N, Akaza H, Koiso K. Gan To Kagaku Ryoho; 1991 Nov 10; 18(14):2369-74. PubMed ID: 1719939 [Abstract] [Full Text] [Related]
11. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T, Tozawa K, Yamada Y, Sakagami H, Ueda K, Kohri K. J Urol; 1996 Sep 10; 156(3):967-71. PubMed ID: 8709375 [Abstract] [Full Text] [Related]
12. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Böhle A, Bock PR. Urology; 2004 Apr 10; 63(4):682-6; discussion 686-7. PubMed ID: 15072879 [Abstract] [Full Text] [Related]
13. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ. Semin Urol Oncol; 1996 Feb 10; 14(1 Suppl 1):10-6. PubMed ID: 8727805 [Abstract] [Full Text] [Related]
14. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, BCG Tokyo 172 Strain Study Group. Urology; 2006 Mar 10; 67(3):545-9. PubMed ID: 16527576 [Abstract] [Full Text] [Related]
15. Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer. Zang Z, Xu H, Yu L, Yang D, Xie S, Shi Y, Li Z, Li J, Wang J, Li M, Guo Y, Gu F. Chin Med J (Engl); 2000 Nov 10; 113(11):1002-6. PubMed ID: 11776112 [Abstract] [Full Text] [Related]
16. [Prevention of postoperative recurrence of bladder cancer: a clinical study]. Yang D, Li S, Wang H, Li X, Liu S, Han W, Hao J, Zhang H. Zhonghua Wai Ke Za Zhi; 1999 Aug 10; 37(8):464-5. PubMed ID: 11829890 [Abstract] [Full Text] [Related]
17. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2]. Wen R, Zhou G, Xie S, Lian B, Sun X, Chen J. Zhonghua Wai Ke Za Zhi; 1998 Apr 10; 36(4):247-8. PubMed ID: 11825381 [Abstract] [Full Text] [Related]
18. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months]. Gilloz A, Sauvage I, Gremillet E, Héritier P, Richard A, el Hajj E, Diez-Yanguas J. J Urol (Paris); 1987 Apr 10; 93(4):197-202. PubMed ID: 3119728 [Abstract] [Full Text] [Related]
19. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H. Eur Urol; 2007 Oct 10; 52(4):1123-29. PubMed ID: 17383080 [Abstract] [Full Text] [Related]
20. Intravesical chemotherapy: how effective is it? Heney NM. Urology; 1988 Mar 10; 31(3 Suppl):17-9. PubMed ID: 3126591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]